How do I install the Glp1 Endoscopy Pre Procedure skill?

Run npx skillmds@latest add dromlakhani/glp1-endoscopy-pre-procedure in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Glp1 Endoscopy Pre Procedure safe to use?

SkillMD's automated safety review verdict for this skill is PASS. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: makes network calls. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Glp1 Endoscopy Pre Procedure?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Glp1 Endoscopy Pre Procedure free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Glp1 Endoscopy Pre Procedure?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Glp1 Endoscopy Pre Procedure by dromlakhani

Name: Glp1 Endoscopy Pre Procedure
Rating: 4.5 (4 reviews)
Author: dromlakhani

Glp1 Endoscopy Pre Procedure

Guide pre-endoscopy management decisions for patients on GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide etc.), deciding whether to proceed, delay, or modify the approach based on GI symptoms, fasting status, and indication. Trigger when a clinician asks about GLP-1 RA and endoscopy, semaglutide before colonoscopy, Ozempic before procedure, or whether to hold a GLP-1 agonist before endoscopy.

dromlakhani Updated Aug 19, 2026 10 repo stars

File contents

GLP-1 RA Pre-Endoscopy Decision Tool

AGA 2024 Rapid Clinical Practice Update

When a patient on a GLP-1 receptor agonist (semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide) is scheduled for endoscopy, work through these 5 steps.

Step 1 — Confirm the GLP-1 RA

Ask:

Which agent and dose?
Dosing frequency (daily vs weekly)?
Indication: diabetes management OR weight loss only?

Indication drives the hold decision in Step 5.

Step 2 — Screen for GI Symptoms

Ask about symptoms in the past 24–48 hours:

Nausea / vomiting
Dyspepsia or bloating
Abdominal distension
Early satiety or feeling of retained food

No symptoms → go to Step 3. Any symptoms → go to Step 4.

Step 3 — Standard Fasting Met + No Symptoms → Proceed

Confirm:

Solids: ≥ 8 hours fasted ✓
Liquids: ≥ 2 hours fasted ✓
No GI symptoms ✓

→ Proceed with standard endoscopy. No additional modifications required.

Step 4 — Symptomatic Patient: Risk-Stratify and Modify

Scenario	Recommended Action
Symptoms mild + elective procedure	Postpone — place patient on clear liquid diet 1 day before, reschedule
Symptoms present + urgent/semi-urgent procedure	Use RSI (Rapid Sequence Induction) with cricoid pressure; ensure airway-trained anaesthesiologist present
High suspicion of retained solid gastric content	Point-of-care ultrasound (USS) of stomach before proceeding
Gastroparesis confirmed or strongly suspected	Consider G-POEM or specialist GI referral before endoscopy

A clear liquid diet the day before is a practical middle-ground when the procedure cannot be postponed but symptoms are mild.

Step 5 — Should the GLP-1 RA Be Held?

Indication	Recommendation
Diabetes management	Do NOT hold — stopping risks hyperglycaemia; proceed with standard precautions
Weight loss only (no diabetes)	May consider holding for 1 dosing interval (1 week for weekly agents, 1 day for daily agents) if symptomatic or elective

Key principle: The decision to proceed or postpone is driven by symptoms and aspiration risk — not by the drug alone. Do not reflexively cancel all endoscopies in patients on GLP-1 RAs.

Guardrails

Do not cancel by default — lack of symptoms + adequate fasting = safe to proceed
Never stop GLP-1 RA in a diabetic patient without endocrine/medical cover
Symptoms > drug history — a symptomatic patient needs modification regardless of whether the drug was held
This tool applies to upper and lower GI endoscopy (colonoscopy, EGD, EUS, ERCP)

Source: Hashash JG, Thompson CC, Wang AY. AGA Rapid Clinical Practice Update on Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy. Clin Gastroenterol Hepatol 2024;22:705–707. DOI: 10.1016/j.cgh.2023.11.002

---name: glp1-endoscopy-pre-proceduredescription: Guide pre-endoscopy management decisions for patients on GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide etc.), deciding whether to proceed, delay, or modify the approach based on GI symptoms, fasting status, and indication. Trigger when a clinician asks about GLP-1 RA and endoscopy, semaglutide before colonoscopy, Ozempic before procedure, or whether to hold a GLP-1 agonist before endoscopy.---# GLP-1 RA Pre-Endoscopy Decision Tool### AGA 2024 Rapid Clinical Practice UpdateWhen a patient on a GLP-1 receptor agonist (semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide) is scheduled for endoscopy, work through these 5 steps.---## Step 1 — Confirm the GLP-1 RAAsk:- Which agent and dose?- Dosing frequency (daily vs weekly)?- Indication: **diabetes management** OR **weight loss only**?> Indication drives the hold decision in Step 5.---## Step 2 — Screen for GI SymptomsAsk about symptoms in the past 24–48 hours:- Nausea / vomiting- Dyspepsia or bloating- Abdominal distension- Early satiety or feeling of retained food**No symptoms → go to Step 3.****Any symptoms → go to Step 4.**---## Step 3 — Standard Fasting Met + No Symptoms → ProceedConfirm:- Solids: ≥ 8 hours fasted ✓- Liquids: ≥ 2 hours fasted ✓- No GI symptoms ✓→ **Proceed with standard endoscopy.**No additional modifications required.---## Step 4 — Symptomatic Patient: Risk-Stratify and Modify| Scenario | Recommended Action ||---|---|| Symptoms mild + elective procedure | **Postpone** — place patient on clear liquid diet 1 day before, reschedule || Symptoms present + urgent/semi-urgent procedure | Use **RSI (Rapid Sequence Induction)** with cricoid pressure; ensure airway-trained anaesthesiologist present || High suspicion of retained solid gastric content | **Point-of-care ultrasound (USS)** of stomach before proceeding || Gastroparesis confirmed or strongly suspected | Consider **G-POEM** or specialist GI referral before endoscopy |> A **clear liquid diet the day before** is a practical middle-ground when the procedure cannot be postponed but symptoms are mild.---## Step 5 — Should the GLP-1 RA Be Held?| Indication | Recommendation ||---|---|| **Diabetes management** | **Do NOT hold** — stopping risks hyperglycaemia; proceed with standard precautions || **Weight loss only (no diabetes)** | **May consider holding** for 1 dosing interval (1 week for weekly agents, 1 day for daily agents) if symptomatic or elective |> **Key principle:** The decision to proceed or postpone is driven by **symptoms and aspiration risk** — not by the drug alone. Do not reflexively cancel all endoscopies in patients on GLP-1 RAs.---## Guardrails- Do not cancel by default — lack of symptoms + adequate fasting = safe to proceed- Never stop GLP-1 RA in a diabetic patient without endocrine/medical cover- Symptoms > drug history — a symptomatic patient needs modification regardless of whether the drug was held- This tool applies to **upper and lower GI endoscopy** (colonoscopy, EGD, EUS, ERCP)---**Source:** Hashash JG, Thompson CC, Wang AY. AGA Rapid Clinical Practice Update on Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy. *Clin Gastroenterol Hepatol* 2024;22:705–707. DOI: [10.1016/j.cgh.2023.11.002](https://doi.org/10.1016/j.cgh.2023.11.002)

Frequently asked questions